Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer

Clinical trial NCT00060307 · COMPLETED

Trial details

NCT number: NCT00060307
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Renal Cell Cancer Stage III Renal Cell Cancer Stage IV Renal Cell Cancer

Start date: 2003-05-01
Primary completion: 2007-05-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.